Perimeter Medical Imaging AI, Inc. announced that patient randomization is underway at Mayo Clinic in Florida, the most recent clinical site to be initiated as part of an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined with its proprietary ImgAssist AI software. Patient recruitment and randomization is underway at the Mayo Clinic in Florida, which is one of the sites where are studying the combination of the Perimeter B-Series medical imaging platform with artificial intelligence software. Combining high-resolution optical coherence tomography with AI algorithms can potentially help surgeons better identify regions of interest during breast conserving surgeries, with the aim of improving patient outcomes and reducing healthcare costs.
Perimeter Medical Imaging AI, Inc.
Equities
PINK
CA71385D1078
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 CAD | +4.00% | +7.22% | -57.38% |
22/04 | Perimeter Medical Imaging AI, Inc.(TSXV:PINK) dropped from S&P/TSX Venture Composite Index | CI |
16/04 | Transcript : Perimeter Medical Imaging AI, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.38% | 24.76M | |
-4.01% | 14.91B | |
-35.44% | 2.96B | |
-14.59% | 2.41B | |
-11.01% | 1.48B | |
-.--% | 1.12B | |
+58.24% | 583M | |
+94.87% | 515M | |
+12.77% | 244M | |
+0.12% | 230M |
- Stock Market
- Equities
- PINK Stock
- News Perimeter Medical Imaging AI, Inc.
- Perimeter Medical Imaging Ai, Inc. Announces Patient Randomization Underway At Clinical Trial Site At Mayo Clinic in Florida